Paul van der Horst
Président chez MOLECURE S.A.
Postes actifs de Paul van der Horst
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MOLECURE S.A. | Président | - | - |
| Directeur/Membre du Conseil | 14/01/2022 | - | |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | - | - |
| Immunetune | Directeur/Membre du Conseil | - | - |
Historique de carrière de Paul van der Horst
Anciens postes connus de Paul van der Horst
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GALAPAGOS NV | Public Communications Contact | - | 01/04/2021 |
| Corporate Officer/Principal | - | - | |
Van Lanschot Kempen NV (Broker)
 Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Analyst-Equity | - | - |
Formation de Paul van der Horst
| Erasmus University Rotterdam | Doctorate Degree |
Statistiques
Internationale
| Pays-Bas | 4 |
| Belgique | 3 |
| Pologne | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Analyst-Equity | 1 |
Sectorielle
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GALAPAGOS NV | Health Technology |
| MOLECURE S.A. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Van Lanschot Kempen NV (Broker)
Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Finance |
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Commercial Services |
| Immunetune |
- Bourse
- Insiders
- Paul van der Horst
- Expérience
